Copyright
©The Author(s) 2019.
World J Hepatol. May 27, 2019; 11(5): 421-441
Published online May 27, 2019. doi: 10.4254/wjh.v11.i5.421
Published online May 27, 2019. doi: 10.4254/wjh.v11.i5.421
Figure 4 Predicted reduction in hepatitis C virus-related productivity loss with direct acting antiviral treatment.
Compared to no treatment, direct acting antiviral treatment for GT1 hepatitis C virus patients was predicted to reduce productivity loss in Singapore, South Korea (A and B: Adapted with permission from Younossi et al[104], 2017) and China (C: Graph generated using data reported in Ye et al[91], 2018); modelling was over a one-year time horizon.
- Citation: Xie Q, Xuan JW, Tang H, Ye XG, Xu P, Lee IH, Hu SL. Hepatitis C virus cure with direct acting antivirals: Clinical, economic, societal and patient value for China. World J Hepatol 2019; 11(5): 421-441
- URL: https://www.wjgnet.com/1948-5182/full/v11/i5/421.htm
- DOI: https://dx.doi.org/10.4254/wjh.v11.i5.421